-
1
-
-
0015012375
-
Carcinoma of the lung, a comparative series of 687 cases
-
Lince L and Lulu DJ: Carcinoma of the lung, a comparative series of 687 cases. Arch Surg 102: 103-107, 1971.
-
(1971)
Arch Surg
, vol.102
, pp. 103-107
-
-
Lince, L.1
Lulu, D.J.2
-
2
-
-
0015875563
-
Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma
-
Host H: Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma. Cancer Chemother Rep 4: 161-164, 1973.
-
(1973)
Cancer Chemother Rep
, vol.4
, pp. 161-164
-
-
Host, H.1
-
3
-
-
84880323799
-
Adriamycin in advanced bronchogenic carcinoma
-
Cotes FP, Takita H and Holland JF: Adriamycin in advanced bronchogenic carcinoma. Cancer 34: 161-164, 1973.
-
(1973)
Cancer
, vol.34
, pp. 161-164
-
-
Cotes, F.P.1
Takita, H.2
Holland, J.F.3
-
4
-
-
0020626047
-
Adriamycin and Cytoxan in the treatment of inoperable lung cancer
-
Hoeltgen TM, McIntyre JM, Perlia CP, Lagakos SN, Stolbach LL and Bennett JM: Adriamycin and Cytoxan in the treatment of inoperable lung cancer. Cancer 51: 2005-2012, 1983. (Pubitemid 13092448)
-
(1983)
Cancer
, vol.51
, Issue.11
, pp. 2005-2012
-
-
Hoeltgen, T.M.1
MacIntyre, J.M.2
Perlia, C.P.3
-
5
-
-
0017662186
-
Combination chemotherapy of bronchogenic carcinoma, non-oat cell
-
Livingston RB: Combination chemotherapy of bronchogenic carcinoma, non-oat cell. Cancer Treat Rev 4: 153-165, 1997.
-
(1997)
Cancer Treat Rev
, vol.4
, pp. 153-165
-
-
Livingston, R.B.1
-
6
-
-
0018598523
-
Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer
-
Casper ES, Grail RI, Kelsey DP, Critkovic E and Golbey RB: Phase II study of high dose cis-diammine-dichloroplatinum (II) in the treatment of non-small cell lung cancer. Cancer Treat Rep 63: 2107-2109, 1979. (Pubitemid 10138998)
-
(1979)
Cancer Treatment Reports
, vol.63
, Issue.11-12
, pp. 2107-2109
-
-
Casper, E.S.1
Gralla, R.J.2
Kelsen, D.P.3
-
7
-
-
0019492001
-
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules
-
Kelsen DT, Gralla RI, Casper ES, Critkovic E, Magill GB, Krown SE and Golby RB: Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung, randomized trial investigation in two dosage schedule. Ann Intern Med 95: 414-420, 1981. (Pubitemid 11007366)
-
(1981)
Annals of Internal Medicine
, vol.95
, Issue.4
, pp. 414-420
-
-
Gralla, R.J.1
Casper, E.S.2
Kelsen, D.P.3
-
8
-
-
0021962578
-
Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V - A randomized comparison of four cisplatin-containing regimens
-
Ruckdeschel JC, Finkelstein DM, Mason BA and Creech RH: Chemotherapy for metastatic non-small cell bronchogenic carcinoma EST 2575, generation V-a randomized comparison of four cisplatin containing regimens. J Clin Oncol 3: 72-79, 1985. (Pubitemid 15187700)
-
(1985)
Journal of Clinical Oncology
, vol.3
, Issue.1
, pp. 72-79
-
-
Ruckdeschel, J.C.1
Finkelstein, D.M.2
Mason, B.A.3
Creech, R.H.4
-
9
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
-
Non-Small Cell Lung Cancer Collaborative Groups
-
Non-Small Cell Lung Cancer Collaborative Groups: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311: 899-909, 1995.
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
10
-
-
0026428122
-
Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer study group
-
Weiden PL and Piantadosi S: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer study group. J Natl Cancer Inst 83: 266-273, 1991.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 266-273
-
-
Weiden, P.L.1
Piantadosi, S.2
-
11
-
-
0026518780
-
Induction chemotherapy with mitomycin, vindesine and cisplatin for state III unresectable non-small cell lung cancer: Results of the Toronto phase II trial
-
Burkes RL, Ginsberg RL, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson CA, Todd T, Pearson G, Cooper JD, Jones D and Lockwood G: Induction chemotherapy with mitomycin, vindesine and cisplatin for state III unresectable non-small cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 10: 580-586, 1992.
-
(1992)
J Clin Oncol
, vol.10
, pp. 580-586
-
-
Burkes, R.L.1
Ginsberg, R.L.2
Shepherd, F.A.3
Blackstein, M.E.4
Goldberg, M.E.5
Waters, P.F.6
Patterson, C.A.7
Todd, T.8
Pearson, G.9
Cooper, J.D.10
Jones, D.11
Lockwood, G.12
-
12
-
-
0027957929
-
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
-
DOI 10.1056/NEJM199401203300301
-
Rousell R, Gümez-Codina J, Camps C, et al: A randomized trial comparing preparative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330: 153-158, 1994. (Pubitemid 24026882)
-
(1994)
New England Journal of Medicine
, vol.330
, Issue.3
, pp. 153-158
-
-
Rosell, R.1
Gomez-Codina, J.2
Camps, C.3
Maestre, J.4
Padille, J.5
Canto, A.6
Mate, J.L.7
Li, S.8
Roig, J.9
Olazabal, A.10
Canela, M.11
Ariza, A.12
Skacel, Z.13
Morera-Prat, J.14
Abad, A.15
-
13
-
-
0025009172
-
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in Stage III non-small-cell lung cancer
-
Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323: 940-945, 1990. (Pubitemid 20332333)
-
(1990)
New England Journal of Medicine
, vol.323
, Issue.14
, pp. 940-945
-
-
Dillman, R.O.1
Seagren, S.L.2
Propert, K.J.3
Guerra, J.4
Eaton, W.L.5
Perry, M.C.6
Carey, R.W.7
Frei III, E.F.8
Green, M.R.9
-
15
-
-
0028154069
-
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients
-
Le Chevalier T, Brisgand D, Douillard JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 12: 360-367, 1994.
-
(1994)
J Clin Oncol
, vol.12
, pp. 360-367
-
-
Le Chevalier, T.1
Brisgand, D.2
Douillard, J.Y.3
-
17
-
-
0032887573
-
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life
-
Cullen MH, Billingham LJ, Woodroffe CM, et al: Mitomycin, ifosfamide and cisplatin in unresectable non-small cell lung cancer: effects on survival and quality of life. J Clin Oncol 17: 3188-3194, 1999. (Pubitemid 29470650)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.10
, pp. 3188-3194
-
-
Cullen, M.H.1
Billingham, L.J.2
Woodroffe, C.M.3
Chetiyawardana, A.D.4
Gower, N.H.5
Joshi, R.6
Ferry, D.R.7
Rudd, R.M.8
Spiro, S.G.9
Cook, J.E.10
Trask, C.11
Bessell, E.12
Connolly, C.K.13
Tobias, J.14
Souhami, R.L.15
-
18
-
-
0026010571
-
Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non-small cell lung cancer
-
Morton RF, Jett JR, McGinnis WL, et al: Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 115: 681-686, 1991.
-
(1991)
Ann Intern Med
, vol.115
, pp. 681-686
-
-
Morton, R.F.1
Jett, J.R.2
McGinnis, W.L.3
-
19
-
-
0033428433
-
Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment
-
Stathopoulos GP, Dafni UG, Malamos NA, Rigatos S, Kouvatseas G and Moschopoulos N: Induction chemotherapy in non-small cell lung cancer stage IIIa-b and IV and second-line treatment. Anticancer Res 19: 3543-3548, 1999. (Pubitemid 30000218)
-
(1999)
Anticancer Research
, vol.19
, Issue.4 C
, pp. 3543-3548
-
-
Stathopoulos, G.P.1
Dafni, U.G.2
Malamos, N.A.3
Rigatos, S.4
Kouvatseas, G.5
Moschopoulos, N.6
-
21
-
-
0032701095
-
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
-
Crino L, Scagliotti GV, Ricci S, et al: Gemcitabine and cisplatin versus mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol 17: 3522-3530, 1999. (Pubitemid 29517923)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.11
, pp. 3522-3530
-
-
Crino, L.1
Scagliotti, G.V.2
Ricci, S.3
De Marinis, F.4
Rinaldi, M.5
Gridelli, C.6
Ceribelli, A.7
Bianco, R.8
Marangolo, M.9
Di, C.F.10
Sassi, M.11
Barni, S.12
Ravaioli, A.13
Adamo, V.14
Portalone, L.15
Cruciani, G.16
Masotti, A.17
Ferrara, G.18
Gozzelino, F.19
Tonato, M.20
more..
-
22
-
-
0032766474
-
Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study
-
Frasci G, Panza N, Cornelia P, et al: Cisplatin, gemcitabine and paclitaxel in locally advanced or metastatic non-small cell lung cancer: a phase I-II study. J Clin Oncol 17: 2316-2325, 1999. (Pubitemid 29368229)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.8
, pp. 2316-2325
-
-
Frasci, G.1
Panza, N.2
Comella, P.3
Nicolella, G.P.4
Natale, M.5
Manzione, L.6
Bilancia, D.7
Cioffi, R.8
Maiorino, L.9
De Cataldis, G.10
Belli, M.11
Micillo, E.12
Mascia, V.13
Massidda, B.14
Lorusso, V.15
De Lena, M.16
Carpagnano, F.17
Contu, A.18
Pusceddu, G.19
Comella, G.20
more..
-
23
-
-
0032949450
-
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: A phase II randomized Study of the Southern Italy Cooperative Oncology Group
-
Comella P, Frasci G, Panza N, et al: Cisplatin, gemcitabine and vinorelbine combination therapy in advanced non-small cell lung cancer. A phase II randomized study of the Southern Italy Cooperative Oncology Group. J Clin Oncol 17: 1526-1534, 1999. (Pubitemid 29220861)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.5
, pp. 1526-1534
-
-
Comella, P.1
Frasci, G.2
Panza, N.3
Manzione, L.4
Lorusso, V.5
Di, R.G.6
Cioffi, R.7
De Cataldis, G.8
Maiorino, L.9
Bilancia, D.10
Nicolella, G.11
Natale, M.12
Carpagnano, F.13
Pacilio, C.14
De Lena, M.15
Bianco, A.16
Comella, G.17
-
24
-
-
0034076846
-
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the southern Italy cooperative oncology group
-
Comella P, Frasci G, Panza N, et al: Randomized trial comparing cisplatin, gemcitabine and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small cell lung cancer: interim, analysis of a phase III trial of the Southern Italy Cooperative Oncology Group. J Clin Oncol 18: 1451-1457, 2000. (Pubitemid 30205390)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.7
, pp. 1451-1457
-
-
Comella, P.1
Frasci, G.2
Panza, N.3
Manzione, L.4
De Cataldis, G.5
Cioffi, R.6
Maiorino, L.7
Micillo, E.8
Lorusso, V.9
Di, R.G.10
Filippelli, G.11
Lamberti, A.12
Natale, M.13
Bilancia, D.14
Nicolella, G.15
Di, N.A.16
Comella, G.17
-
25
-
-
0345148774
-
Randomized phase III study of gemcitabine-cisplatin versus etoposide- cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer
-
Cardenal F, Lopez-Cabrerizo MP, Anton A, et al: Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced metastatic non-small cell lung cancer. J Clin Oncol 17: 12-18, 1999. (Pubitemid 29022372)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.1
, pp. 12-18
-
-
Cardenal, F.1
Paz, L.-C.M.2
Anton, A.3
Alberola, V.4
Massuti, B.5
Carrato, A.6
Barneto, I.7
Lomas, M.8
Garcia, M.9
Lianes, P.10
Montalar, J.11
Vadell, C.12
Gonzalez-Larriba, J.L.13
Nguyen, B.14
Artal, A.15
Rosell, R.16
-
26
-
-
17344384670
-
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study
-
Crino L, Scagliotti G, Maragolo M, et al: Cisplatin-gemcitabine combination in advanced non-small cell lung cancer: a phase II study. J Clin Oncol 15: 297-303, 1997. (Pubitemid 27020587)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.1
, pp. 297-303
-
-
Crino, L.1
Scagliotti, G.2
Marangolo, M.3
Figoli, F.4
Clerici, M.5
De Marinis, F.6
Salvati, F.7
Cruciani, G.8
Dogliotti, L.9
Pucci, F.10
Paccagnella, A.11
Adamo, V.12
Altavilla, G.13
Incoronato, P.14
Trippetti, M.15
Mosconi, A.M.16
Santucci, A.17
Sorbolini, S.18
Oliva, C.19
Tonato, M.20
more..
-
27
-
-
0033950286
-
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperative oncology group trial
-
Bonomi P, Kim KM, Fairclough D, et al: Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group Trial. J Clin Oncol 18: 623-631, 2000. (Pubitemid 30078543)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.3
, pp. 623-631
-
-
Bonomi, P.1
Kim, K.2
Fairclough, D.3
Cella, D.4
Kugler, J.5
Rowinsky, E.6
Jiroutek, M.7
Johnson, D.8
-
28
-
-
0033941848
-
Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the european organization for research and treatment of cancer lung cancer cooperative group (EORTC 08955)
-
Van Zandwijk N, Smit EF, Kramer GWP, et al: Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage HIA N2 non-small cell lung cancer: a phase II study of the European Organisation for Research and Treatment of Cancer, Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 18: 2658-2664, 2000. (Pubitemid 30463547)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.14
, pp. 2658-2664
-
-
Van Zandwijk, N.1
Smit, E.F.2
Kramer, G.W.P.3
Schramel, F.4
Gans, S.5
Festen, J.6
Termeer, A.7
Schlosser, N.J.J.8
Debruyne, C.9
Curran, D.10
Giaccone, G.11
-
29
-
-
17344384668
-
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
-
Sandler AB, Nemunaitis J, Denham C, et al: A phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small cell lung cancer. J Clin Oncol 18: 122-130, 2000. (Pubitemid 30036345)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.1
, pp. 122-130
-
-
Sandler, A.B.1
Nemunaitis, J.2
Denham, C.3
Von Pawel, J.4
Cormier, Y.5
Gatzemeier, U.6
Mattson, K.7
Manegold, C..8
Palmer, M.C.9
Gregor, A.10
Nguyen, B.11
Niyikiza, C.12
Einhorn, L.H.13
-
30
-
-
0027952504
-
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
-
Depierre A, Chastang CI, Quoix E, et al: Vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. Ann Oncol 5: 37-42, 1994. (Pubitemid 24049852)
-
(1994)
Annals of Oncology
, vol.5
, Issue.1
, pp. 37-42
-
-
Depierre, A.1
Chastang, C.2
Quoix, E.3
Lebeau, B.4
Blanchon, F.5
Paillot, N.6
Lemarie, E.7
Milleron, B.8
Moro, D.9
Clavier, J.10
Herman, D.11
Tuchais, E.12
Jacoulet, P.13
Brechot, J.M.14
Cordier, J.F.15
Solal-Celigny, P.16
Badri, N.17
Besenval, M.18
-
31
-
-
0032885644
-
Phase I/II study of vinorelbine, mitomycin, and cisplatin for stage IIIB or IV non-small-cell lung cancer
-
Furuse K, Kawahora M, Nishiwaji Y, et al: Phase I/II study of vinorelbine, mitomycin and cisplatin for stage IIIb or IV nonsmall cell lung cancer. J Clin Oncol 17: 3195-3200, 1999. (Pubitemid 29470651)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.10
, pp. 3195-3200
-
-
Furuse, K.1
Kawahara, M.2
Nishiwaki, Y.3
Fukuoka, M.4
Takada, M.5
Miyashita, M.6
Ohashi, Y.7
-
32
-
-
0032830577
-
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer
-
De Vore RF, Johnson DH, Crawford J, et al: Phase II study of irinotecan plus cisplatin in patients with advanced non-small cell lung cancer. J Clin Oncol 17: 2710-2720, 1999. (Pubitemid 29415227)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.9
, pp. 2710-2720
-
-
DeVore, R.F.1
Johnson, D.H.2
Crawford, J.3
Garst, J.4
Dimery, I.W.5
Eckardt, J.6
Eckhardt, S.G.7
Elfring, G.L.8
Schaaf, L.J.9
Hanover, C.K.10
Miller, L.L.11
-
33
-
-
0034104328
-
Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group
-
Von Pawel J, von Roemeling R, Gatzemeier V, et al: Tirapazamine plus cisplatin versus cisplatin in advanced non-small cell lung cancer: a report of the International CATAPULTI Study Group. J Clin Oncol 18: 1351-1359, 2000. (Pubitemid 30159856)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.6
, pp. 1351-1359
-
-
Von Pawel, J.1
Von Roemeling, R.2
Gatzemeier, U.3
Boyer, M.4
Elisson, L.O.5
Clark, P.6
Talbot, D.7
Augustin, R.8
Butler, T.W.9
Hirsh, V.10
Olver, I.11
Bergman, B.12
Ayoub, J.13
Richardson, G.14
Dunlop, D.15
Arcenas, A.16
Vescio, R.17
Viallet, J.18
Treat, J.19
-
34
-
-
0031462199
-
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer
-
DOI 10.1023/A:1008219125746
-
Miller VA, Ng KK, Grant SC, et al: Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small cell lung cancer. Ann Oncol 8: 1269-1271, 1997. (Pubitemid 28164084)
-
(1997)
Annals of Oncology
, vol.8
, Issue.12
, pp. 1269-1271
-
-
Miller, V.A.1
Ng, K.R.2
Grant, S.C.3
Kindler, H.4
Pizzo, B.5
Heelan, R.T.6
Von Roemeling, R.7
Kris, M.G.8
-
35
-
-
0030823326
-
Paclitaxel (1-h infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: Results of a multicenter phase II trial
-
Greco A and Hainsworth JD: Paclitaxel (1-h infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial. Semin Oncol 24: 512-514, S12-S17, 1997.
-
(1997)
Semin Oncol
, vol.24
-
-
Greco, A.1
Hainsworth, J.D.2
-
36
-
-
0032978689
-
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer
-
Belani CP, Keams CM, Zuhowski EG, et al: Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combinations paclitaxel and carboplatin in patients with metastatic non-small cell lung cancer. J Clin Oncol 17: 676-684, 1999. (Pubitemid 29075257)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.2
, pp. 676-684
-
-
Belani, C.P.1
Kearns, C.M.2
Zuhowski, E.G.3
Erkmen, K.4
Hiponia, D.5
Zacharski, D.6
Engstrom, C.7
Ramanathan, R.K.8
Capozzoli, M.J.9
Aisner, J.10
Egorin, M.J.11
-
37
-
-
8044220286
-
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer
-
Huizing MT, Giaccone G, van Warmerdam LJC, et al: Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small cell lung cancer. J Clin Oncol 15: 317-329, 1997. (Pubitemid 27020590)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.1
, pp. 317-329
-
-
Huizing, M.T.1
Giaccone, G.2
Van Warmerdam, L.J.C.3
Rosing, H.4
Bakker, P.J.M.5
Vermorken, J.B.6
Postmus, P.E.7
Van Zandwijk, N.8
Koolen, M.G.J.9
Ten, B.H.W.W.10
Van Der, V.W.J.F.11
Bierhorst, F.J.12
Lai, A.13
Dalesio, O.14
Pinedo, H.M.15
Veenhof, C.H.N.16
Beijnen, J.H.17
-
39
-
-
0032761165
-
Combination chemotherapy with carboplatin, docetaxel, gemcitabine in advanced non-small cell lung cancer: A phase II study
-
Pectasides D, Aspropotamitis A, Halikia A, et al: Combination chemotherapy with carboplatin, docetaxel, gemcitabine in advanced non-small cell lung cancer: a phase II study. J Clin Oncol 17: 3816-3821, 1999.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3816-3821
-
-
Pectasides, D.1
Aspropotamitis, A.2
Halikia, A.3
-
40
-
-
0032977557
-
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non- small-cell lung cancer
-
Iaffaioli RV, Tortoriello A, Facchini G, et al: Phase I-II study of gemcitabine and carboplatin in stage IIIb-IV non-small cell lung cancer. J Clin Oncol 17: 921-926, 1999. (Pubitemid 29109324)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.3
, pp. 921-926
-
-
Iaffaioli, R.V.1
Tortoriello, A.2
Facchini, G.3
Caponigro, F.4
Gentile, M.5
Marzano, N.6
Gravina, A.7
Dimitri, P.8
Costagliola, G.9
Ferraro, A.10
Ferrante, G.11
De Marino, V.12
Illiano, A.13
-
41
-
-
0030751045
-
Weekly paclitaxel in patients with advanced lung cancer: Preliminary data from a phase II trial
-
Akerly W, Choy H, Safran H, et al: Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial. Semin Oncol 24: S12-10-S12-13, 1997.
-
(1997)
Semin Oncol
, vol.24
-
-
Akerly, W.1
Choy, H.2
Safran, H.3
-
42
-
-
0030005778
-
Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer
-
Chang AY, de Vore R and Johnson D: Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer. Semin Oncol 23: S19-S21, 1996.
-
(1996)
Semin Oncol
, vol.23
-
-
Chang, A.Y.1
De Vore, R.2
Johnson, D.3
-
43
-
-
4143146439
-
Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: Arandomized phase III trial
-
DOI 10.1093/annonc/mdh260
-
Stathopoulos GP, Veslemes M, Georgatou N, et al: Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small cell lung cancer: a randomized phase III trial. Ann Oncol 15: 1048-1055, 2004. (Pubitemid 39089781)
-
(2004)
Annals of Oncology
, vol.15
, Issue.7
, pp. 1048-1055
-
-
Stathopoulos, G.P.1
Veslemes, M.2
Georgatou, N.3
Antoniou, D.4
Giamboudakis, P.5
Katis, K.6
Tsavdaridis, D.7
Rigatos, S.K.8
Dimitroulis, I.9
Bastani, S.10
Loukides, S.11
Vergos, K.12
Marossis, K.13
Grigoratou, T.14
Kalatzi, E.15
Charalambatou, M.16
Paspalli, A.17
Michalopoulou, P.18
Stoka, M.19
Gerogianni, A.20
more..
-
44
-
-
7844245430
-
Salvage treatment with paclitaxel and gemcitabine for patients with non- small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: A multicenter phase II study
-
DOI 10.1023/A:1008497322508
-
Androulakis N, Kouroussis C, Kakolyris S, et al: Salvage treatment with paclitaxel and gemcitabine for patients with non-small cell lung cancer after cisplatin or docetaxel-based chemotherapy: a multicenter phase II study. Ann Oncol 9: 1127-1130, 1998. (Pubitemid 28518153)
-
(1998)
Annals of Oncology
, vol.9
, Issue.10
, pp. 1127-1130
-
-
Androulakis, N.1
Kouroussis, C.2
Kakolyris, S.3
Tzannes, S.4
Papadakis, E.5
Papadimitriou, C.6
Geroyianni, A.7
Georgopoulou, T.8
Dimopoulou, I.9
Souglakos, J.10
Kotsakis, A.11
Vardakis, N.12
Hatzidaki, D.13
Georgoulias, V.14
-
45
-
-
14444270379
-
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine
-
DOI 10.1002/(SICI)1097-0142(19981115)83:10<2083::A
-
Kouroussis CH, Androulakis N, Kakolyris S, et al: First-line treatment of advanced non-small cell lung carcinoma with docetaxel and vinorelbene. Cancer 83: 2083-2090, 1998. (Pubitemid 28525389)
-
(1998)
Cancer
, vol.83
, Issue.10
, pp. 2083-2090
-
-
Kourousis, C.1
Androulakis, N.2
Kakolyris, S.3
Souglakos, J.4
Maltezakis, G.5
Metaxaris, G.6
Chalkiadakis, G.7
Samonis, G.8
Vlachonikolis, J.9
Georgoulias, V.10
-
46
-
-
0033014303
-
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
-
Georgoulias V, Kouroussis CH, Androulakis N, et al: Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial. J Clin Oncol 17: 914-920, 1999. (Pubitemid 29109323)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.3
, pp. 914-920
-
-
Georgoulias, V.1
Kouroussis, C.2
Androulakis, N.3
Kakolyris, S.4
Dimopoulos, M.-A.5
Papadakis, E.6
Bouros, D.7
Apostolopoulou, F.8
Papadimitriou, C.9
Agelidou, A.10
Hatzakis, K.11
Kalbakis, K.12
Kotsakis, A.13
Vardakis, N.14
Vlachonicolis, J.15
-
47
-
-
0034095853
-
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens
-
Fossella FV, de Vore R, Kerr RN, et al: Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens. J Clin Oncol 18: 2354-2362, 2000. (Pubitemid 30415821)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.12
, pp. 2354-2362
-
-
Fossella, F.V.1
DeVore, R.2
Kerr, R.N.3
Crawford, J.4
Natale, R.R.5
Dunphy, F.6
Kalman, L.7
Miller, V.8
Lee, J.S.9
Moore, M.10
Gandara, D.11
Karp, D.12
Vokes, E.13
Kris, M.14
Kim, Y.15
Gamza, F.16
Hammershaimb, L.17
-
48
-
-
0034062813
-
Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer
-
Miller VA, Krug LM, Ng KK, et al: Phase II trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer. J Clin Oncol 18: 1346-1350, 2000. (Pubitemid 30159855)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.6
, pp. 1346-1350
-
-
Miller, V.A.1
Krug, L.M.2
Ng, K.K.3
Pizzo, B.4
Perez, W.5
Heelan, R.T.6
Kris, M.G.7
-
49
-
-
0029044996
-
Summary of phase II data of docetaxel (taxotere) an active agent in the 1st and 2nd line treatment of advanced non-small cell lung cancer (NSCLC)
-
Fossella FV, Lee JS, Berille J, et al: Summary of phase II data of docetaxel (taxotere) an active agent in the 1st and 2nd line treatment of advanced non-small cell lung cancer (NSCLC). Semin Oncol 22: S22-S29, 1995.
-
(1995)
Semin Oncol
, vol.22
-
-
Fossella, F.V.1
Lee, J.S.2
Berille, J.3
-
50
-
-
0033988085
-
Activity of docetaxel in platinum-treated non-small-cell lung cancer: Results of a phase II multicenter trial
-
Gandara DR, Vokes E, Green M, et al: Activity of docetaxel in platinum-treated non-small cell lung cancer: results of a phase II multicenter trial. J Clin Oncol 18: 131-135, 2000. (Pubitemid 30036346)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.1
, pp. 131-135
-
-
Gandara, D.R.1
Vokes, E.2
Green, M.3
Bonomi, P.4
Devore, R.5
Comis, R.6
Carbone, D.7
Karp, D.8
Belani, C.9
-
51
-
-
0034069620
-
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum- based chemotherapy
-
Shepherd FA, Dancey J, Ramlau R, et al: Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 18: 2095-2103, 2000. (Pubitemid 30324363)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.10
, pp. 2095-2103
-
-
Shepherd, F.A.1
Dancey, J.2
Ramlau, R.3
Mattson, K.4
Gralla, R.5
O'Rourke, M.6
Levitan, N.7
Gressot, L.8
Vincent, M.9
Burkes, R.10
Coughlin, S.11
Kim, Y.12
Berille, J.13
-
52
-
-
0033932224
-
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer
-
Frasci G, Lovusso V, Panza N, et al: Gemcitabine plus vinorelbine alone in elderly patients with advanced non-small cell lung cancer. J Clin Oncol 18: 2529-2536, 2000. (Pubitemid 30432518)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.13
, pp. 2529-2536
-
-
Frasci, G.1
Lorusso, V.2
Panza, N.3
Comella, P.4
Nicolella, G.5
Bianco, A.6
De Cataldis, G.7
Iannelli, A.8
Bilancia, D.9
Belli, M.10
Massidda, B.11
Piantedosi, F.12
Comella, G.13
De Lena, M.14
-
53
-
-
10244229739
-
Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC)
-
Furuse K, Fukuoka M, el at Randomized study of vinorelbine (vrb) versus vindesine (VDS) in previously untreated stage IIIb or IV non-small cell lung cancer (NSCLC). Ann Oncol 7: 815-820, 1996. (Pubitemid 26345872)
-
(1996)
Annals of Oncology
, vol.7
, Issue.8
, pp. 815-820
-
-
Furuse, K.1
Fukuoka, M.2
Kuba, M.3
Yamori, S.4
Nakai, Y.5
Negoro, S.6
Katagami, N.7
Takada, Y.8
Kinuwaki, E.9
Kawahara, M.10
Kubota, K.11
Sakuma, A.12
Niitani, H.13
-
54
-
-
0033967260
-
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer
-
Lorusso V, Carpagnano F, Frasci G, et al: Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small cell lung cancer. J Clin Oncol 18: 405-411, 2000. (Pubitemid 30056431)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.2
, pp. 405-411
-
-
Lorusso, V.1
Carpagnano, F.2
Frasci, G.3
Panza, N.4
Di, R.G.5
Cisternino, M.L.6
Napoli, G.7
Orlando, S.8
Cinieri, S.9
Brunetti, C.10
Palazzo, S.11
De Lena, M.12
-
55
-
-
0032982848
-
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial
-
Crino L. Mosconi AM. Scagliotti G, et ai. Gemcitabine as second-line treatment for advanced non-small cell lung cancer: a phase II trial. J Clin Oncol 17: 2081-2085, 1999. (Pubitemid 29318838)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.7
, pp. 2081-2085
-
-
Crino, L.1
Mosconi, A.M.2
Scagliotti, G.3
Selvaggi, G.4
Novello, S.5
Rinaldi, M.6
Della, G.M.7
Gridelli, C.8
Rossi, A.9
Calandri, C.10
De Marinis, F.11
Noseda, M.12
Tonato, M.13
-
56
-
-
0031015192
-
Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer
-
Oshita F, Noda K, Nishiwaki Y, et al: Phase II study of irinotecan and etoposide in patients with metastatic non-small cell lung cancer (NSCLC). J Clin Oncol 15: 304-309, 1997. (Pubitemid 27020588)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.1
, pp. 304-309
-
-
Oshita, F.1
Noda, K.2
Nishiwaki, Y.3
Fujita, A.4
Kurita, Y.5
Nakabayashi, T.6
Tobise, K.7
Abe, S.8
Suzuki, S.9
Hayashi, I.10
Kawakami, Y.11
Matsuda, T.12
Tsuchiya, S.13
Takahashi, S.14
Tamura, T.15
Saijo, N.16
-
57
-
-
0032908148
-
Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study
-
Rusthoven JJ, Eisenhauer E, Butts C, et al: Multitargeted antifolate ly231514 as first-line chemotherapy for patients with advanced non-small cell lung cancer: a phase II study. J Clin Oncol 17: 1194-1199, 1999. (Pubitemid 29162943)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.4
, pp. 1194-1199
-
-
Rusthoven, J.J.1
Eisenhauer, E.2
Butts, C.3
Gregg, R.4
Dancey, J.5
Fisher, B.6
Iglesias, J.7
-
58
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
-
Non-Small Cell Lung Cancer Collaborative Group
-
Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311: 899-909, 1991.
-
(1991)
BMJ
, vol.311
, pp. 899-909
-
-
-
59
-
-
9744260262
-
Twenty-five years of treating advanced NSCLC: What have we achieved?
-
Giaccone G: Twenty-five years of treating advanced NSCLC: what have we achieved? Ann Oncol 15: Siv81-Siv83, 2004.
-
(2004)
Ann Oncol
, vol.15
-
-
Giaccone, G.1
|